Identification and characterization of biomarkers of organophosphorus exposures in humans

Advances in Experimental Medicine and Biology

Volumn 660, Issue , 2010, Pages 61-71

  Kim, Jerry H ^a   Stevens, Richard C ^a   MacCoss, Michael J ^a   Goodlett, David R ^a   Scherl, Alex ^a   Richter, Rebecca J ^a   Suzuki, Stephanie M ^a   Furlong, Clement E ^a  

^a NONE

Author keywords

Acylpeptide hydrolase; Affinity purification; Biomarkers of OP exposure; Butyrylcholinesterase; Immunomagnetic beads; Mass spectrometry

Indexed keywords

ACYLAMINO ACID RELEASING ENZYME; BIOLOGICAL MARKER; CHOLINESTERASE; ORGANOPHOSPHATE INSECTICIDE;

ARTICLE; BIOLOGICAL MONITORING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME PURIFICATION; ERYTHROCYTE; FUNCTIONAL PROTEOMICS; HALF LIFE TIME; HUMAN; IMMUNOMAGNETIC SEPARATION; MASS SPECTROMETRY; METABOLITE; NEUROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; PESTICIDE SPRAYING; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; SENSITIVITY AND SPECIFICITY;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL MARKERS; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; ERYTHROCYTES; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; ORGANOPHOSPHORUS COMPOUNDS; PEPTIDE HYDROLASES; PESTICIDES; PROTEOMICS; TRITOLYL PHOSPHATES;

EID: 78649419571     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-350-3_7     Document Type: Article

References (31)

1. Aldridge WN (1954) Tricresyl phosphates and cholinesterase. Biochem J 56(2):185-189
2. Anderson L, Anderson NG (1977) High resolution two-dimensional electrophoresis of human plasma proteins. Proc Natl Acad Sci USA 74(12):5421-5425
3. Black RM, Harrison JM, Read RW(1999) The interaction of sarin and soman with plasma proteins: the identification of a novel phosphonylation site. Arch Toxicol 73(2):123-126 (Pubitemid 29226171)
4. Casida JE, Eto M, Baron RL (1961) Biological activity of a tri-o-cresyl phosphate metabolite. Nature 191:1396-1397
5. Casida JE, Quistad GB (2004) Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem Res Toxicol 17(8):983-998 (Pubitemid 39108669)
6. Fidder A, Hulst AG, Noort D, de Ruiter R, van der Schans MJ, Benschop HP, Lanenberg JP (2002) Retrospective detection of exposure to organophosphorus anti-cholinesterases: mass spectrometric analysis of phosphylated human butyrylcholinesterase. Chem Res Toxicol 15(4):582-590 (Pubitemid 34406420)
7. Fujino T, Watanabe K, Beppu M, Kikugawa K, Yasuda H (2000) Identification of oxidized protein hydrolase of human erythrocytes as acylpeptide hydrolase. Biochim Biophys Acta 1478(1):102-112 (Pubitemid 30136143)
8. Furlong CE, Cole TB, MacCoss M, Richter R, Costa LG (2005) Biomarkers for Exposure and of Sensitivity to Organophosphorus [OP] Compounds. Proceedings of the BALPA Air Safety and Cabin Air Quality International Aero Industry Conference. April 20-21. Imperial College, London.
9. Gade W, Brown JL (1978) Purification and partial characterization of alpha-N-acylpeptide hydrolase from bovine liver. J Biol Chem 253(14):5012-5018 (Pubitemid 8382173)
10. Grunwald J, Marcus D, Papier Y, Raveh L, Pittel Z, Asani Y (1997) Large-scale purification and long-term stability of human butyrylcholinesterase: a potential bioscavenger drug. J Biochem Biophys Methods 34(2):123-135 (Pubitemid 27204971)
11. Hill RH, Head SL, Baker S, GreggM, Shealy DB, Bailey SL,Williams CC, Sampson EJ, Needham LL (1995) Pesticide residues in urine of adults living in the United States: reference range concentrations. Environ Res 71(2):99-108 (Pubitemid 26425582)
12. Holmstedt B (1959) Pharmacology of organophosphorus cholinesterase inhibitors. Pharmacol Rev 11:567-688
13. Li B, Sedlacek M, Manoharan I, Boopathy R, Duysen EG, Masson P, Lockridge O (2005) Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem Pharmacol 70(11):1673-1684 (Pubitemid 41540360)
14. Lockridge O, La Du B (1978) Comparison of atypical and usual human serum cholinesterase. Purification, number of active sites, substrate affinity, and turnover number. J Biol Chem 253(2):361-366 (Pubitemid 8267656)
15. Lockridge O, Schopfer LM, Winger G, Woods JH (2005) Large scale purification of butyrylcholinesterase from human plasma suitable for injection into monkeys; a potential new therapeutic for protection against cocaine and nerve agent toxicity. J Med Chem Biol Radiol Def 3:5095
16. Lotti M(1995) Cholinesterase inhibition: complexities in interpretation. Clin Chem 41:1814-1818
17. Mehrani H (2004) Simplified procedures for purification and stabilization of human plasma butyrylcholinesterase. Process Biochem 39(7):877-882 (Pubitemid 38329546)
18. Parascandola J (1995) The Public Health Service and Jamaica ginger paralysis in the 1930s. Public Health Reports 110(3):361-363
19. Peeples ES, Schopfer LM, Duysen EG, Spaulding R, Voelker T, Thompson CM, Lockridge O (2005) Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry. Toxicol Sci 83(2):303-312 (Pubitemid 40227900)
20. Polhuijs M, Langenberg JP, Benschop HP (1997) New method for retrospective detection of exposure to organophosphorus anticholinesterases: application to alleged sarin victims of Japanese terrorists. Toxicol Appl Pharmacol 146(1):156-161 (Pubitemid 27406407)
21. Quistad GB, Klintenberg R, Casida JE (2005) Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants. Toxicol Sci 86(2):291-299 (Pubitemid 41418642)
22. Ralston JS, Main AR, Kilpathrick BF, Chasson AL (1983) Use of procainamide gels in the purification of human and horse serum cholinesterases. Biochem J 211(1):243-250 (Pubitemid 13104397)
23. Richards PG, Johnson MK, Ray DE (2000) Identification of acylpeptide hydrolase as a sensitive site for reaction with organophosphorus compounds and a potential target for cognitive enhancing drugs. Mol Pharmacol 58(3):577-583
24. Saboori AM, Newcombe DS (1990) Human monocyte carboxylesterase. Purification and kinetics. J Biol Chem 265(32):19792-19799 (Pubitemid 120013932)
25. Shimizu K, Kiuchi Y, Ando K, Hayakawa M, Kikugawa K (2004) Coordination of oxidized protein hydrolase and the proteasome in the clearance of cytotoxic denatured proteins. Biochem Biophys Res Commun 324(1):140-146 (Pubitemid 39311471)
26. Tsunasawa S, Narita K, Ogata K (1975) Purification and properties of acylamino acid-releasing enzyme from rat liver. J Biochem 77(1):89-102
27. Vose SC, Holland NT, Eskenazi B, Casida JE (2007) Lysophosphatidylcholine hydrolases of human erythrocytes, lymphocytes, and brain: sensitive targets of conserved specificity for organophosphorus delayed neurotoxicants. Toxicol Appl Pharmacol 224(1):98-104 (Pubitemid 47404620)
28. Whiteaker JR, Zhao L, Zhang HY, Feng LC, Piening BD, Anderson L, Paulovich AG (2007) Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal Biochem 362(1):44-54 (Pubitemid 46198803)
29. Winder C, Balouet JC (2002) The toxicity of commercial jet oils. Environ Res 89(2):146-164 (Pubitemid 34680884)
30. Yamaguchi M, Kambayashi D, Toda J, Sano T, Toyoshima S, Hojo H (1999) Acetylleucine chloromethyl ketone, an inhibitor of acylpeptide hydrolase, induces apoptosis of U937 cells. Biochem Biophys Res Commun 263(1):139-142 (Pubitemid 29443653)
31. Yamin R, Bagchi S, Hildebrant R, Scaloni A,Widom RL, Abraham CR (2007) Acyl peptide hydrolase, a serine proteinase isolated from conditioned medium of neuroblastoma cells, degrades the amyloid-beta peptide. J Neurochem 100(2):458-467 (Pubitemid 46011006)